The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats
出版年份 2023 全文链接
标题
The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats
作者
关键词
-
出版物
Diabetology & Metabolic Syndrome
Volume 15, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-31
DOI
10.1186/s13098-023-01196-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signalling pathway in diabetic cardiomyopathy
- (2023) Rosalinda Madonna et al. CARDIOVASCULAR RESEARCH
- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- (2023) Connie W. Tsao et al. CIRCULATION
- Dapagliflozin Treatment Augments Bioactive Phosphatidylethanolamine Concentrations in Kidney Cortex Membrane Fractions of Hypertensive Diabetic db/db Mice and Alters the Density of Lipid Rafts in Mouse Proximal Tubule Cells
- (2023) Mohammed F. Gholam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial
- (2023) Moritz J. Hundertmark et al. CIRCULATION
- Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins
- (2023) Raúl Lelio Sanz et al. CURRENT HYPERTENSION REPORTS
- Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease
- (2023) Raysa S. Farias et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function
- (2023) Deepika Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Influence of Isolated Resistance Exercise on Cardiac Remodeling, Myocardial Oxidative Stress, and Metabolism in Infarcted Rats
- (2023) Eder Anderson Rodrigues et al. Antioxidants
- Dynamic evolution of left ventricular strain and microvascular perfusion assessed by speckle tracking echocardiography and myocardial contrast echocardiography in diabetic rats: Effect of dapagliflozin
- (2023) Juan Liu et al. Frontiers in Cardiovascular Medicine
- Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants
- (2022) Francesca Romana Prandi et al. HEART FAILURE REVIEWS
- The Role of Oxidative Stress in the Aging Heart
- (2022) Luana U Pagan et al. Antioxidants
- Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
- (2022) Ren Jie Phang et al. CARDIOVASCULAR RESEARCH
- SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis
- (2022) Hongyan Liu et al. Current Diabetes Reports
- Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway
- (2022) Cuan-Cuan Wang et al. JOURNAL OF DRUG TARGETING
- Gliflozins in the Management of Cardiovascular Disease
- (2022) Eugene Braunwald NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
- (2022) Husam M. Salah et al. Journal of Cardiovascular Translational Research
- Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus
- (2022) Camila Moreno Rosa et al. Antioxidants
- Clinical and Safety Outcomes with GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study
- (2022) Khary Edwards et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- (2022) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
- (2022) Misganaw Asmamaw Mengstie et al. Frontiers in Endocrinology
- Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease
- (2022) Chang Dai et al. ESC Heart Failure
- Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials
- (2021) Lunwen Rao et al. ACTA DIABETOLOGICA
- Dapagliflozin: a sodium–glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling
- (2021) Yuze Zhang et al. Cardiovascular Diabetology
- Off‐label use of SGLT inhibitors among adults in T1D Exchange Registry
- (2021) Michael S. Hughes et al. DIABETES OBESITY & METABOLISM
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aerobic Exercise During Advance Stage of Uncontrolled Arterial Hypertension
- (2021) Luana U. Pagan et al. Frontiers in Physiology
- Real‐world data of 12‐month adjunct sodium‐glucose co‐transporter‐2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: Improved HbA1c without diabetic ketoacidosis
- (2021) Jochen Seufert et al. DIABETES OBESITY & METABOLISM
- SGLT2 inhibitors: the statins of the 21st century
- (2021) Eugene Braunwald EUROPEAN HEART JOURNAL
- Heart failure in diabetes
- (2021) Stanislovas S. Jankauskas et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
- (2021) Ryo Bamba et al. Journal of Cachexia Sarcopenia and Muscle
- Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
- (2021) Teresa Salvatore et al. Biomedicines
- SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
- (2020) Martin R. Cowie et al. Nature Reviews Cardiology
- The nephrological perspective on SGLT-2 inhibitors in type 1 diabetes
- (2020) Pieter Gillard et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Influence of intermittent fasting on myocardial infarction-induced cardiac remodeling
- (2019) K. Okoshi et al. BMC Cardiovascular Disorders
- Diabetic Cardiomyopathy
- (2019) Wolfgang H. Dillmann CIRCULATION RESEARCH
- Sodium–glucose co‐transporter 2 inhibition with empagliflozin improves cardiac function in non‐diabetic rats with left ventricular dysfunction after myocardial infarction
- (2019) Salva R. Yurista et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
- (2019) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2019) Jae Hyun Bae et al. Scientific Reports
- Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
- (2019) Alana Aragón-Herrera et al. BIOCHEMICAL PHARMACOLOGY
- Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy
- (2018) André C. Carpentier CANADIAN JOURNAL OF CARDIOLOGY
- Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus
- (2018) R. Gimenes et al. Cardiovascular Diabetology
- SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
- (2018) Subodh Verma et al. DIABETOLOGIA
- Cardiac metabolism — A promising therapeutic target for heart failure
- (2018) Hannah Noordali et al. PHARMACOLOGY & THERAPEUTICS
- Exercise during transition from compensated left ventricular hypertrophy to heart failure in aortic stenosis rats
- (2018) David R. A. Reyes et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
- (2018) Laween Uthman et al. Frontiers in Physiology
- Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus
- (2016) C. M. Rosa et al. Cardiovascular Diabetology
- The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria
- (2016) Jonathan Z. Long et al. CELL
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
- (2016) Hiddo J.L. Heerspink et al. CIRCULATION
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Rutin administration attenuates myocardial dysfunction in diabetic rats
- (2015) Julliano F C Guimaraes et al. Cardiovascular Diabetology
- Influence ofN-Acetylcysteine on Oxidative Stress in Slow-Twitch Soleus Muscle of Heart Failure Rats
- (2015) Paula F. Martinez et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low Intensity Physical Exercise Attenuates Cardiac Remodeling and Myocardial Oxidative Stress and Dysfunction in Diabetic Rats
- (2015) C. Gimenes et al. Journal of Diabetes Research
- Dapagliflozin reduces the amplitude of shortening and Ca2+ transient in ventricular myocytes from streptozotocin-induced diabetic rats
- (2014) N. N. Hamouda et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Aldosterone Blockade Reduces Mortality without Changing Cardiac Remodeling in Spontaneously Hypertensive Rats
- (2013) Marcelo D.M. Cezar et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in rats
- (2011) Marcos F. Minicucci et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started